Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-(4-Chlorophenyl)glutaric acid, with the CAS number 35271-74-0, is a white solid compound that is utilized in organic synthesis. It is characterized by its chemical structure, which includes a glutaric acid backbone with a 4-chlorophenyl group attached to the third carbon.

35271-74-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 35271-74-0 Structure
  • Basic information

    1. Product Name: 3-(4-Chlorophenyl)glutaric acid
    2. Synonyms: 3-(4-CHLOROPHENYL)-PENTANEDIOIC ACID;3-(4-CHLOROPHENYL)GLUTARIC ACID;CBI-BB ZERO/006271;BETA-(4-CHLOROPHENYL)GLUTARIC ACID;B-(4-CHLOROPHENYL) GLUTARIC ACID;-(4-Chlorophenyl)glutaricacid;3-(4-chlorophenyl) glutarate;b-(p-Chlorophenyl)glutaric Acid
    3. CAS NO:35271-74-0
    4. Molecular Formula: C11H11ClO4
    5. Molecular Weight: 242.66
    6. EINECS: 252-477-1
    7. Product Categories: Miscellaneous Biochemicals;(intermediate of baclofen);Aromatics;Raw material
    8. Mol File: 35271-74-0.mol
  • Chemical Properties

    1. Melting Point: 164-166°C
    2. Boiling Point: 394.4 °C at 760 mmHg
    3. Flash Point: 192.3 °C
    4. Appearance: White Solid
    5. Density: 1.396 g/cm3
    6. Vapor Pressure: 6.29E-07mmHg at 25°C
    7. Refractive Index: N/A
    8. Storage Temp.: Sealed in dry,Room Temperature
    9. Solubility: Soluble in dimethyl sulfoxide. Slightly soluble in methanol.
    10. PKA: 4.01±0.10(Predicted)
    11. BRN: 1976828
    12. CAS DataBase Reference: 3-(4-Chlorophenyl)glutaric acid(CAS DataBase Reference)
    13. NIST Chemistry Reference: 3-(4-Chlorophenyl)glutaric acid(35271-74-0)
    14. EPA Substance Registry System: 3-(4-Chlorophenyl)glutaric acid(35271-74-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: 36/37/38
    3. Safety Statements: 26-36
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 35271-74-0(Hazardous Substances Data)

35271-74-0 Usage

Uses

Used in Pharmaceutical Industry:
3-(4-Chlorophenyl)glutaric acid is used as a synthetic intermediate for the development of various pharmaceutical compounds. Its unique chemical structure allows it to be a key component in the synthesis of drugs targeting specific medical conditions.
Used in Organic Synthesis:
In the field of organic chemistry, 3-(4-Chlorophenyl)glutaric acid serves as a valuable building block for creating a wide range of organic molecules. Its versatility in chemical reactions makes it an essential compound for researchers and chemists working on the development of new molecules with potential applications in various industries.
Used in Research and Development:
3-(4-Chlorophenyl)glutaric acid is also used in research and development settings, where it can be employed to study the properties and behavior of various organic compounds. Its unique structure and reactivity make it an interesting subject for scientific investigations, potentially leading to new discoveries and advancements in the field of chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 35271-74-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,2,7 and 1 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 35271-74:
(7*3)+(6*5)+(5*2)+(4*7)+(3*1)+(2*7)+(1*4)=110
110 % 10 = 0
So 35271-74-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H11ClO4/c12-9-3-1-7(2-4-9)8(5-10(13)14)6-11(15)16/h1-4,8H,5-6H2,(H,13,14)(H,15,16)/p-2

35271-74-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L18693)  3-(4-Chlorophenyl)glutaric acid, 98%   

  • 35271-74-0

  • 5g

  • 391.0CNY

  • Detail
  • Alfa Aesar

  • (L18693)  3-(4-Chlorophenyl)glutaric acid, 98%   

  • 35271-74-0

  • 25g

  • 1390.0CNY

  • Detail

35271-74-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(4-chlorophenyl)pentanedioic acid

1.2 Other means of identification

Product number -
Other names 3-(4-Chlorophenyl)pentanedioic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:35271-74-0 SDS

35271-74-0Relevant articles and documents

Hydrogen-Bonding Catalyzed Ring-Closing C?O/C?O Metathesis of Aliphatic Ethers over Ionic Liquid under Metal-Free Conditions

Wang, Huan,Zhao, Yanfei,Zhang, Fengtao,Wu, Yunyan,Li, Ruipeng,Xiang, Junfeng,Wang, Zhenpeng,Han, Buxing,Liu, Zhimin

supporting information, p. 11850 - 11855 (2020/05/16)

O-heterocycles have wide applications, and their efficient and green synthesis is very interesting. Herein, we report hydrogen-bonding catalyzed ring-closing metathesis of aliphatic ethers to O-heterocycles over ionic liquid (IL) catalyst under metal- and solvent-free conditions. The IL 1-butylsulfonate-3-methylimidazolium trifluoromethanesulfonate ([SO3H-BMIm][OTf]) is discovered to show outstanding performance, better than the reported catalysts. An interface effect plays an important role in mediating the reaction rate due to the immiscibility between the products and the IL catalyst, and the products can be spontaneously separated. NMR analysis and DFT calculation suggest that a pair of cation and anion of [SO3H-BMIm][OTf] could form three strong H-bonds with an ether molecule, which catalyze the ether transformation via a cyclic oxonium intermediate. A series of O-heterocycles including tetrahydrofurans, tetrahydropyrans, morpholines and dioxane can be obtained from their corresponding ethers in excellent yields (e.g., >99 %). This work opens an efficient and metal-free way to produce O-heterocycles from aliphatic ethers.

Preparation method for refining high-purity 3-(4-chlorobenzene) glutaric acid

-

Paragraph 0034-0081, (2019/01/14)

The invention discloses a preparation method for refining a high-purity 3-(4-chlorobenzene) glutaric acid. The preparation method comprises the steps of synthesizing a crude product of 3-(4-chlorobenzene) glutaric acid and purifying the crude product. An excellent technical effect is achieved and the contents of major impurity raw materials intermediate a and intermediate b as well as process impurities in the crude product of 3-(4-chlorobenzene) glutaric acid can be obviously reduced, in the manner of adopting a synthesis method for controlling the crude product of 3-(4-chlorobenzene) glutaric acid, purification processes from different documentaries and decontamination with methyl isobutyl ketone; the purity of 3-(4-chlorobenzene) glutaric acid detected with HPLC can reach up to above 99.8%; the limits of impurities are all less than 0.1%.

CHEMICAL COMPOUNDS AS ATF4 PATHWAY INHIBITORS

-

Page/Page column 179; 180, (2019/01/06)

The invention is directed to substituted bridged cycloalkane derivatives. Specifically, the invention is directed to compounds according to Formula (IIIQ): wherein X6', a, b, C8', D8', L82', L83', R81', R82', R83', R84', R85', R86', z82', z84', z85', and z86' are as defined herein; or salts thereof. The compounds of the invention are inhibitors of the ATF4 pathway. Accordingly, invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting the ATF4 pathway and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

A balufen green industrial production method (by machine translation)

-

Paragraph 0023; 0028, (2017/05/02)

The invention discloses a balufen green preparation method, which belongs to the technical field of drug synthesis. The method to the chlorobenzene as a starting material, by Knoevenagel condensation, alkali hydrolysis, sub-amide, alkali hydrolysis and Hofmann degradation 5 step reaction make the consistent with the clinical pharmaceutical balufen. Raw materials of this invention extremely easy, low cost, simple synthesis operation, are basically all aqueous reaction under the condition of, environmental pollution is very small, high yield, is a brand new industrial production balufen method. (by machine translation)

Synthesis and biological evaluation of pentanedioic acid derivatives as farnesyltransferase inhibitors

Yang, Liuqing,Liu, Wei,Mei, Hanbing,Zhang, Yuan,Yu, Xiaojuan,Xu, Yufang,Li, Honglin,Huang, Jin,Zhao, Zhenjiang

, p. 671 - 676 (2015/04/27)

Structure-based virtual screening of a commercial library identified pentanedioic acid derivatives (6 and 13b) as a kind of novel scaffold farnesyltransferase inhibitors (FTIs). Chemical modifications of the lead compounds, biological assays and analysis of the structure-activity relationships (SAR) were conducted to discover more potent FTIs. Some of them displayed excellent inhibition against FTase, and among them, the most active compound 13n with an IC50 value of 0.0029 μM and SAR analysis might be helpful to the discovery of more potent FTIs. This journal is

Three multicomponent reactions of 3,5-dimethyl-4-nitroisoxazole

Adamo, Mauro F.A.,Konda, Vivekananda R.,Donati, Donato,Sarti-Fantoni, Piero,Torroba, Tomas

, p. 9741 - 9745 (2008/02/12)

The title compound is used to prepare 3-arylglutaric acids, bis-isoxazoles and bis-pyrazoles from commercially available materials. The methodologies described have afforded important synthetic intermediates in high yields and without the use of chromatography.

Synthesis of 2,5-thiazole butanoic acids as potent and selective αvβ3 integrin receptor antagonists with improved oral pharmacokinetic properties

Wendt, John A.,Wu, Hongwei,Stenmark, Heather G.,Boys, Mark L.,Downs, Victoria L.,Penning, Thomas D.,Chen, Barbara B.,Wang, Yaping,Duffin, Tiffany,Finn, Mary Beth,Keene, Jeffery L.,Engleman, V. Wayne,Freeman, Sandra K.,Hanneke, Melanie L.,Shannon, Kristen E.,Nickols, Maureen A.,Steininger, Christina N.,Westlin, Marissa,Klover, Jon A.,Westlin, William,Nickols, G. Allen,Russell, Mark A.

, p. 845 - 849 (2007/10/03)

We describe a series of 2,5 thiazole containing compounds, which are potent antagonists of the integrin αvβ3 and show selectivity relative to the other integrins, such as αIIbβ 3 and αvβ6. These analogs were demonstrated to have high bioavailability relative to other relative heterocyclic analogs.

Enzymatic desymmetrization of 3-arylglutaric acid anhydrides

Fryszkowska, Anna,Komar, Marta,Koszelewski, Dominik,Ostaszewski, Ryszard

, p. 2475 - 2485 (2007/10/03)

Optically active (R)- and (S)-3-arylglutaric acid monoesters 3 were synthesized in quantitative yields and good stereoselectivities by lipase-catalyzed desymmetrization of the corresponding 3-arylglutaric anhydrides 2 with alcohols. It was observed that the stereochemical outcome of the reaction was influenced by the substituents present on the aromatic ring. The influence of the enzyme, alcohol, and solvent was systematically examined. Absolute configurations of the monoesters 3 were assigned by chemical correlation to corresponding lactones 4.

Solid-phase synthesis of a nonpeptide RGD mimetic library: New selective αvβ3 integrin antagonists

Sulyok,Gibson,Goodman,H?lzemann,Wiesner,Kessler

, p. 1938 - 1950 (2007/10/03)

The solid-phase synthesis of a low molecular weight RGD mimetic library is described. Activities of the compounds in inhibiting the interaction of ligands, vitronectin and fibrinogen, with isolated immobilized integrins αvβ3 and αIIbβ3 were determined in a screening assay. Highly active and selective nonpeptide αvβ3 integrin antagonists with regard to orally bioavailability were developed, based on the aza-glycine containing lead compound 1. An important variation is the substitution of the aspartic amide of 1 by an aromatic residue. Furthermore, different guanidine mimetics have been incorporated to improve the pharmacokinetic profile. Exchange of the β-amino acid NH by a methylene moiety in one set of RGD mimetics leads to the azacarba analogue compounds representing a novel peptidomimetic approach, which should increase the metabolic stability.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 35271-74-0